Page last updated: 2024-08-24

capecitabine and Experimental Neoplasms

capecitabine has been researched along with Experimental Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Hu, X; Li, L; Liu, Z; Wan, G; Wang, J; Wu, X; Yu, L; Zhang, Q1
Deng, X; Feng, H; Feng, Y; He, Y; Jiang, W; Li, J; Li, Z; Liu, D; Lu, Y; Shi, T; Wang, Z; Zhang, H; Zhang, J1
Cao, Y; Huang, G; Lai, Q; Liu, Y; Nie, G; Sun, M; Sun, Y; Wang, X; Xing, X; Yang, Y; Yin, L; Yu, G; Zhang, Y1
Andrews, D; Beyar-Katz, O; Hariharan, S; Kerbel, RS; Magidey, K; Man, S; Miller, V; Pham, E; Shaked, Y; Wu, FT; Xu, P1
Guo, Y; Li, Z; Qin, J; Xu, C; Xu, H; Yu, Y1
Flatmark, K; Folkvord, S; Olsen, DR; Røe, K; Seierstad, T; Skretting, A1
Ishikawa, T; Ishitsuka, H; Sawada, N; Sekiguchi, F; Tanaka, Y1
Arasaki, M; Horii, I; Ishitsuka, H; Kohchi, Y; Kuruma, I; Masubuchi, K; Miwa, M; Murasaki, C; Sawada, N; Shimma, N; Tahara, H; Umeda, I; Ura, M1

Other Studies

8 other study(ies) available for capecitabine and Experimental Neoplasms

ArticleYear
Discovery of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives as novel tubulin polymerization inhibitors for treatment of cancer.
    European journal of medicinal chemistry, 2019, Dec-15, Volume: 184

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Mice; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Polymerization; Purines; Pyridones; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured

2019
Design, synthesis and biological evaluation of novel o-aminobenzamide derivatives as potential anti-gastric cancer agents in vitro and in vivo.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Mice, Inbred Strains; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tumor Cells, Cultured

2022
Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 06-27, Volume: 114, Issue:26

    Topics: A549 Cells; Administration, Oral; Animals; Capecitabine; Drug Screening Assays, Antitumor; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Time Factors

2017
Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy.
    Cancer research, 2016, 10-15, Volume: 76, Issue:20

    Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow Cells; Capecitabine; Cell Line, Tumor; Female; Humans; Maximum Tolerated Dose; Mice; Neoplasms, Experimental

2016
Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip.
    Integrative biology : quantitative biosciences from nano to macro, 2016, 10-10, Volume: 8, Issue:10

    Topics: A549 Cells; Bioartificial Organs; Capecitabine; Drug Evaluation, Preclinical; Equipment Design; Equipment Failure Analysis; Flow Injection Analysis; Hep G2 Cells; Humans; Lab-On-A-Chip Devices; Metabolic Flux Analysis; Neoplasms, Experimental; Organ Culture Techniques; Tissue Array Analysis; Toxicity Tests; Viscera

2016
Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice.
    Neoplasia (New York, N.Y.), 2007, Volume: 9, Issue:5

    Topics: Animals; Antineoplastic Agents; Capecitabine; Deoxycytidine; Diffusion; Female; Fluorouracil; HT29 Cells; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Organoplatinum Compounds; Oxaliplatin; Transplantation, Heterologous; Treatment Outcome

2007
X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:10

    Topics: Animals; Antineoplastic Agents; Capecitabine; Combined Modality Therapy; Deoxycytidine; Enzyme Induction; Fluorouracil; Humans; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Thymidine Phosphorylase; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; X-Ray Therapy

1999
The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine.
    Bioorganic & medicinal chemistry, 2000, Volume: 8, Issue:7

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Capecitabine; Carbamates; Carboxylic Ester Hydrolases; Deoxycytidine; Drug Delivery Systems; Floxuridine; Fluorouracil; Humans; Intestines; Kinetics; Liver; Macaca fascicularis; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Prodrugs; Structure-Activity Relationship; Substrate Specificity; Transplantation, Heterologous

2000